MedySapiens
MedySapiens Inc. is at the clinical forefront of providing testing and analysis solutions for rare diseases in newborns, with the mission and vision of “providing opportunities for a healthy life through fast and accurate diagnostic technology for rare diseases”.
Our Bio-IT fusion technologies provide optimal solutions and services as below:
- Diagnostic panel/kit capable of simultaneously testing 265 genes that cause over 220 rare diseases
- MedyCVi® is an AI-driven diagnostic S/W that identifies and evaluates genetic variants associated with rare genetic diseases
We outperform in the following areas:
- Optimized experimental protocol of minimized blood volume requirement, especially for sick newborns in the NICU
- Reduced TAT, turnaround time (less than 3 days)
- Improved accuracy & specificity through AI-based assessment of genetic variants
- AI solution provides clinicians with speed & genomic counselors’ level of support
- For more information, visit: https://www.medysapiens.com/en
